Synergistic effects of nitric oxide and prostaglandins on renal escape from vasopressin-induced antidiuresis

被引:18
|
作者
Murase, T
Tian, Y
Fang, XY
Verbalis, JG
机构
[1] Georgetown Univ, Div Endocrinol & Metab, Dept Med, Washington, DC 20007 USA
[2] Georgetown Univ, Div Nephrol & Hypertens, Dept Med, Washington, DC 20007 USA
关键词
aquaporin-2;
D O I
10.1152/ajpregu.00065.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Recent results from our laboratories indicate that renal escape from AVP-induced antidiuresis is accompanied by marked downregulation of kidney aquaporin-2 (AQP2) and AVP V2 receptors. The present studies evaluated the effect of nitric oxide (NO) and PG synthesis blockade on escape from antidiuresis. dDAVP-infused rats were water loaded (WL) for 5 days. L-NAME, an NO synthesis inhibitor, or diclofenac, a cyclooxygenase inhibitor, was infused subcutaneously beginning 1 day before WL. As early as 2 days after WL, urine volume increased and urine osmolality decreased, indicating the onset of escape. Endogenous NO synthesis, measured as urinary NO2 + NO3 excretion, was significantly increased in the WL group compared with the non-WL controls during all 5 days of WL. L-NAME (20 mg.kg(-1).day(-1)) markedly decreased urine volume on days 4 and 5 of WL, indicating inhibition of the escape phenomenon. Kidney AQP2 protein was significantly increased by this dose of L-NAME as well. A lower dose of L-NAME (10 mg.kg(-1).day(-1)) or diclofenac (2.5 mg.kg(-1).day(-1)) did not significantly affect the escape phenomenon by itself, but the combination of L-NAME and diclofenac showed a marked inhibitory effect on the escape phenomenon, which was also accompanied by a significant increase in kidney AQP2 expression. These results therefore suggest that renal NO and PG both play important roles in escape from AVP-induced antidiuresis by acting synergistically to downregulate kidney AQP2 expression.
引用
收藏
页码:R354 / R362
页数:9
相关论文
共 50 条
  • [41] Endothelium-dependent, vasopressin-induced contractions in rabbit renal arteries
    Streefkerk, JO
    Pfaffendorf, M
    van Zwieten, PA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 (06) : 703 - 709
  • [42] VASOPRESSIN-INDUCED MOTOR EFFECTS - LOCALIZATION OF A SENSITIVE SITE IN THE AMYGDALA
    WILLCOX, BJ
    POULIN, P
    VEALE, WL
    PITTMAN, QJ
    BRAIN RESEARCH, 1992, 596 (1-2) : 58 - 64
  • [43] CHRONIC NITRIC OXIDE SYNTHASE INHIBITION INCREASES RENAL VASOPRESSIN EFFECTS IN NORMOTENSIVE RAT
    Verzicco, I.
    Tedeschi, S.
    Barouhiel, E.
    Graiani, G.
    Ugolotti, M.
    Cavazzini, S.
    Bergamaschi, E.
    Brusasco, I.
    Di Spigno, F.
    Vignali, A.
    Volpi, R.
    Perlini, S.
    Montanari, A.
    Borghetti, A.
    Cabassi, A.
    JOURNAL OF HYPERTENSION, 2019, 37 : E198 - E199
  • [44] RENAL ESCAPE FROM VASOPRESSIN - ROLE OF PRESSURE DIURESIS
    HALL, JE
    MONTANI, JP
    WOODS, LL
    MIZELLE, HL
    AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 250 (05): : F907 - F916
  • [45] URINARY CALCIUM EXCRETION OF WOMEN WITH BREAST CANCER DURING POST-HYPOPHYSECTOMY POLYURIA, SPONTANEOUS INTERPHASE AND VASOPRESSIN-INDUCED ANTIDIURESIS
    GARDNER, B
    WITT, J
    GORDAN, GS
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1962, 109 (01): : 71 - &
  • [46] Nitric oxide and prostaglandins mediate vascular effects of estrogen
    Hövelborn, T
    Yu, G
    Hoffmeister, HM
    Beyer, ME
    EUROPEAN HEART JOURNAL, 2002, 23 : 461 - 461
  • [47] Nitric oxide and prostaglandins mediate vascular effects of estrogen
    Hövelborn, T
    Yu, G
    Hoffmeister, M
    Beyer, ME
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (06) : A28 - A28
  • [48] Nitric oxide and prostaglandins modulate the hemodynamic effects of estrogen
    Beyer, ME
    Yu, G
    Hoffmeister, HM
    CIRCULATION, 1998, 98 (17) : 659 - 659
  • [49] ROLE OF INCREASED RENAL ARTERIAL-PRESSURE IN ESCAPE FROM ANTIDIURETIC EFFECTS OF VASOPRESSIN
    HALL, JE
    MONTANI, JP
    KIDNEY INTERNATIONAL, 1985, 27 (01) : 192 - 192
  • [50] Social stress inhibits the nitric oxide effect on the corticotropin-releasing hormone- but not vasopressin-induced pituitary-adrenocortical responsiveness
    Bugajski, J
    Gadek-Michalska, A
    Borycz, J
    Glód, R
    BRAIN RESEARCH, 1999, 817 (1-2) : 220 - 225